OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

S. K. Aurora, D. W. Dodick, C. C. Turkel, R. E. Degryse, S. D. Silberstein, R. B. Lipton, H. C. Diener, M. F. Brin

Research output: Contribution to journalArticlepeer-review

591 Scopus citations

Fingerprint

Dive into the research topics of 'OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences